combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline do combine inhibitors agonists guidance What classes of diabetes SGLT-2 inhibitors, GLP-1 receptor agonists,

Pharmacokinetic data indicate that fasting plasma glucose (FPG) levels begin to decrease within two weeks, and steady-state plasma concentrations are typically achieved after six weeks of weekly dosing [59]

L., et al., Vildagliptin, a Dipeptidyl PeptidaseIV Inhibitor, Improves ModelAssessed Cell Function in Patients With Type 2 Diabetes, Journal of Clinical Endocrinology and Metabolism 90, no

doi: 10.1016/j.molmet.2022.101533, 50

Most people who use meal replacement products experience no negative side effects at all

Given their effectiveness in controlling blood glucose and HbA1c levels, with additional weight loss benefits and minimal intrinsic risk of hypoglycemic episodes, GLP-1 RAs are now considered the first-line injectables for optimal glucose control in diabetic patients even before insulin treatment [18]

doi: 10.1038/ki.2013.427